Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

Ken Griffin's hedge fund Citadel has placed a £305 million ($390 million) short bet against GSK PLC GSK, marking the largest wager against the UK pharma giant in over a decade, reported the Financial Times. The position, disclosed to the UK's Financial Conduct Authority, amounts to 0.51% of GSK's outstanding shares.GSK's Rally Faces A Reality CheckGSK stock has climbed 8.20% in the past month, fueled by a £2 billion ($2.5 billion approx.) stock buyback and strong HIV and cancer drug sales. Yet, it still tra ...